’Proud that two made in India vaccines get emergency use approval’: PM Modi

  • 'Congratulations India. Congratulations to our hardworking scientists and innovators,' PM Modi tweeted
  • India has authorised the emergency use of two Covid-19 vaccines

Edited By Sangeeta Ojha
Updated3 Jan 2021, 12:27 PM IST
Prime Minister Narendra Modi gestures during laying the foundation stone for the permanent campus of IIM-Sambalpur, Odisha, via video conferencing in New Delhi on Saturday. (ANI Photo)
Prime Minister Narendra Modi gestures during laying the foundation stone for the permanent campus of IIM-Sambalpur, Odisha, via video conferencing in New Delhi on Saturday. (ANI Photo)

Prime Minister Narendra Modi today said it would make every Indian proud that the two Covid-19 vaccines that have been given approval by the Drugs Controller General of India (DCGI) are 'made in India'.

"It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion," said PM Modi.

India has authorised the emergency use of two Covid-19 vaccines developed by AstraZeneca and Oxford University and by Bharat Biotech, DCGI said today.

"We reiterate our gratitude to doctors, medical staff, scientists, police personnel, sanitation workers and all Corona warriors for the outstanding work done, that too in adverse circumstances. We will remain eternally grateful to them for saving many lives," PM Modi said in another tweet.

PM Modi called the development a 'decisive turning point', 'accelerating the road' to a healthier and Covid-free nation.

"A decisive turning point to strengthen a spirited fight! DCGI granting approval to vaccines of Serum Institute of India and Bharat Biotech accelerates the road to a healthier and COVID-free nation. Congratulations India. Congratulations to our hardworking scientists and innovators," PM Modi tweeted.

"The... vaccines of Serum Institute (AstraZeneca/Oxford vaccine) and Bharat Biotech are being approved for restricted use in emergency situations," the Drugs Controller General of India, V.G. Somani, said at a briefing.

Meanwhile, India on Sunday recorded 18,177 fresh cases of coronavirus, taking the total number of positive cases in the country to 1,03,23,965, according to Union Health Ministry. With this, the total number of active cases in the country now stands at 2,47,220.

Catch all the Budget News , Business News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:3 Jan 2021, 12:27 PM IST
HomeNewsIndia’Proud that two made in India vaccines get emergency use approval’: PM Modi

Get Instant Loan up to ₹10 Lakh!

  • Employment Type

    Most Active Stocks

    Bharat Electronics

    301.50
    03:56 PM | 23 JUL 2024
    -11.1 (-3.55%)

    Tata Steel

    160.05
    03:58 PM | 23 JUL 2024
    -0.3 (-0.19%)

    Tata Power

    416.35
    03:58 PM | 23 JUL 2024
    -7.9 (-1.86%)

    NTPC

    382.35
    03:58 PM | 23 JUL 2024
    8.8 (2.36%)
    More Active Stocks

    Market Snapshot

    • Top Gainers
    • Top Losers
    • 52 Week High

    Network 18 Media & Investments

    85.30
    03:59 PM | 23 JUL 2024
    7.2 (9.22%)

    Asahi India Glass

    699.50
    03:29 PM | 23 JUL 2024
    55.15 (8.56%)

    CE Info Systems

    2,455.50
    03:59 PM | 23 JUL 2024
    193.45 (8.55%)

    Borosil Renewables

    518.25
    03:49 PM | 23 JUL 2024
    39.35 (8.22%)
    More from Top Gainers

    Recommended For You

      More Recommendations

      Gold Prices

      • 24K
      • 22K
      Bangalore
      75,195.00-315.00
      Chennai
      75,122.00-535.00
      Delhi
      75,048.00-169.00
      Kolkata
      75,561.00417.00

      Fuel Price

      • Petrol
      • Diesel
      Bangalore
      102.86/L0.00
      Chennai
      100.75/L-0.23
      Kolkata
      104.95/L0.00
      New Delhi
      94.72/L0.00
      OPEN IN APP
      HomeMarketsPremiumInstant LoanBudget